Anti-arthritic efficacy of Bombax ceiba ethanolic extract in a murine model for rheumatoid arthritis using in vivo, in vitro and radiological analysis
Bioinformation · 31.08.2023 · 19 (8) · 833-839
DOI: 10.6026/97320630019833 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformation, online erschienen am 31.08.2023. Verfasst von Bhargavi Posinasetty und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Data Management, Prometrika LLC, Cambridge - MA 02140, United States. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a multisystem autoimmune disease that causes discomfort, synovial membrane inflammation, peripheral joint inflammation, morning stiffness, articular tissue loss, and restricted joint movement. In the present study, we aim to explore the anti-arthritic efficacy of Bombax ceiba ethanolic extract in a Freund's Complete Adjuvant-induced arthritis, in murine model. The hot soxhlet method was used to extract dried aerial components of Bombax ceiba using an ethyl alcohol: water (70:30) ratio. Bombax ceiba ethanolic extract at two doses of 200 and 400 mg/kg was investigated in Wistar rats against Freund's full adjuvant-induced chronic immunological arthritis. Anti-arthritis efficacy was studied utilising morphological research (paw volume, paw diameter, and body weight). On the 28th day, the animals were sacrificed, and haematological parameters, pro-inflammatory cytokines (TNF-alpha, IL-6), cell culture, histological and radiological analysis were performed. BCEE inhibited paw oedema significantly (P 0.05) at a dose of 40mg/Kg, which was corroborated by paw volume and diameter, as well as haematological parameters, in Freund's complete adjuvant-induced arthritis model. The BCEE also significantly reduced pro-inflammatory cytokine levels and the histopathological changes caused by Freund's full adjuvant model. BCEE preserves synovial membranes by enhancing health and has shown a significant anti-arthritic activity. Thus, data confirms the traditional usage of Bombax ceiba for arthritis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Data Management, Prometrika LLC, Cambridge - MA 02140, United States.
- Department of Pharmacology, Sri Venkateswara College of Pharmacy, Chittoor - 517127, A.P., India.
- Department of clinical pharmacology, All India Institute of Medical Sciences, Bhopal, India, 462020.
- Amity Institute of Pharmacy, Amity University Madhya Pradesh (AUMP), Gwalior - 474005, Madhya Pradesh, India.
Zitieren
APA
Posinasetty, B., Chikatipalli, R., Chenchula, S., Kuttiappan, A., G, S., G N A, L., & Audinarayana, N. (2023). Anti-arthritic efficacy of Bombax ceiba ethanolic extract in a murine model for rheumatoid arthritis using in vivo, in vitro and radiological analysis. Bioinformation, 19(8), 833-839. https://doi.org/10.6026/97320630019833
Vancouver
Posinasetty B, Chikatipalli R, Chenchula S, Kuttiappan A, G S, G N A L, et al. Anti-arthritic efficacy of Bombax ceiba ethanolic extract in a murine model for rheumatoid arthritis using in vivo, in vitro and radiological analysis. Bioinformation. 2023;19(8):833-839. doi:10.6026/97320630019833
BibTeX
@article{Posinasetty2023,
author = {Posinasetty, Bhargavi and Chikatipalli, Radhika and Chenchula, Santenna and Kuttiappan, Anitha and G, Swapna and G N A, Lakshmi and Audinarayana, Nelavala},
title = {Anti-arthritic efficacy of Bombax ceiba ethanolic extract in a murine model for rheumatoid arthritis using in vivo, in vitro and radiological analysis},
journal = {Bioinformation},
year = {2023},
volume = {19},
number = {8},
pages = {833--839},
doi = {10.6026/97320630019833}
}
EUVIMED